Rosuvastatin Unknown Status Phase 3 Trials for Coronary Artery Disease Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01378715Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study